Recalls & Warnings July 06, 2022 FDA Warns Kratom Companies for Arthritis, Pain Relief Claims & More On January 30, 2022, the FDA issued warning letters to four sellers of kratom products because they were promoted to treat pain relief, opioid withdrawal, blood sugar control, anxiety, and to treat rheumatoid arthritis
Considered the safest in the industry, the stretchers also incorporate safety lockdowns from front to back, ensuring the patient is secure while in the truck
Risk Summary There are either no or only limited data on the presence of insulin glargine in human milk, the effects on breastfed infant, or the effects on milk production
Supplementary Table 5 details how individual models implemented the scenario components